189 related articles for article (PubMed ID: 26927285)
1. A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
de Denus S; Rouleau JL; Mann DL; Huggins GS; Cappola TP; Shah SH; Keleti J; Zada YF; Provost S; Bardhadi A; Phillips MS; Normand V; Mongrain I; Dubé MP
Pharmacogenomics J; 2017 Mar; 17(2):192-200. PubMed ID: 26927285
[TBL] [Abstract][Full Text] [Related]
2. Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.
Kuriyama A; Urushidani S
Heart Fail Rev; 2019 Jan; 24(1):31-39. PubMed ID: 30054781
[TBL] [Abstract][Full Text] [Related]
3. Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
Wu MY; Chang NC; Su CL; Hsu YH; Chen TW; Lin YF; Wu CH; Tam KW
J Crit Care; 2014 Feb; 29(1):2-9. PubMed ID: 24331943
[TBL] [Abstract][Full Text] [Related]
4. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
5. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
[TBL] [Abstract][Full Text] [Related]
6. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
Rahhal A; Saad MO; Tawengi K; Assi AAR; Habra M; Ahmed D
BMC Cardiovasc Disord; 2019 May; 19(1):127. PubMed ID: 31138146
[TBL] [Abstract][Full Text] [Related]
7. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
[TBL] [Abstract][Full Text] [Related]
8. Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Ballester MR; Roig E; Gich I; Puntes M; Delgadillo J; Santos B; Antonijoan RM
Drug Des Devel Ther; 2015; 9():4291-302. PubMed ID: 26273191
[TBL] [Abstract][Full Text] [Related]
9. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM
Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
11. Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?
Owen DR; MacAllister R; Sofat R
Clin Pharmacol Ther; 2015 Aug; 98(2):119-21. PubMed ID: 25786394
[TBL] [Abstract][Full Text] [Related]
12. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
[TBL] [Abstract][Full Text] [Related]
13. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
Singh D; Shrestha K; Testani JM; Verbrugge FH; Dupont M; Mullens W; Tang WH
J Card Fail; 2014 Jun; 20(6):392-9. PubMed ID: 24704538
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
Kissling KT; Pickworth KK
Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
[TBL] [Abstract][Full Text] [Related]
15. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
[TBL] [Abstract][Full Text] [Related]
16. Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?
De Vecchis R; Ciccarelli A; Pucciarelli A
J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):571-4. PubMed ID: 20588135
[TBL] [Abstract][Full Text] [Related]
17. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.
Peacock WF; Costanzo MR; De Marco T; Lopatin M; Wynne J; Mills RM; Emerman CL;
Cardiology; 2009; 113(1):12-9. PubMed ID: 18931492
[TBL] [Abstract][Full Text] [Related]
18. An exploratory analysis of the competing effects of aggressive decongestion and high-dose loop diuretic therapy in the DOSE trial.
Hanberg JS; Tang WHW; Wilson FP; Coca SG; Ahmad T; Brisco MA; Testani JM
Int J Cardiol; 2017 Aug; 241():277-282. PubMed ID: 28392080
[TBL] [Abstract][Full Text] [Related]
19. Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients.
Cunha FM; Pereira J; Marques P; Ribeiro A; Bettencourt P; Lourenço P
J Cardiovasc Med (Hagerstown); 2020 Jan; 21(1):21-26. PubMed ID: 31714331
[TBL] [Abstract][Full Text] [Related]
20. Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Rohde LE; Rover MM; Figueiredo Neto JA; Danzmann LC; Bertoldi EG; Simões MV; Silvestre OM; Ribeiro ALP; Moura LZ; Beck-da-Silva L; Prado D; Sant'Anna RT; Bridi LH; Zimerman A; Raupp da Rosa P; Biolo A
Eur Heart J; 2019 Nov; 40(44):3605-3612. PubMed ID: 31424503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
